BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 24064019)

  • 1. Lectin-like oxidised LDL receptor-1 as a marker of endothelial dysfunction in Behçet's disease.
    Ozyazgan S; Uzun H; Onal B; Tuzcu A; Ugurlu S; Andican G
    Clin Exp Rheumatol; 2013; 31(3 Suppl 77):71-6. PubMed ID: 24064019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble Lectin-Like Oxidized LDL Receptor 1 as a Possible Mediator of Endothelial Dysfunction in Patients With Metabolic Syndrome.
    Civelek S; Kutnu M; Uzun H; Erdenen F; Altunoglu E; Andican G; Seven A; Sahin AO; Burcak G
    J Clin Lab Anal; 2015 May; 29(3):184-90. PubMed ID: 24798146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial damage in white coat hypertension: role of lectin-like oxidized low-density lipoprotein-1.
    Yavuzer S; Yavuzer H; Cengiz M; Erman H; Altıparmak MR; Korkmazer B; Balci H; Simsek G; Yaldıran AL; Karter Y; Uzun H
    J Hum Hypertens; 2015 Feb; 29(2):92-8. PubMed ID: 25007999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum homocysteine level is increased and correlated with endothelin-1 and nitric oxide in Behçet's disease.
    Er H; Evereklioglu C; Cumurcu T; Türköz Y; Ozerol E; Sahin K; Doganay S
    Br J Ophthalmol; 2002 Jun; 86(6):653-7. PubMed ID: 12034688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymmetric dimethylarginine and nitric oxide levels as signs of endothelial dysfunction in Behcet's disease.
    Sahin M; Arslan C; Naziroglu M; Tunc SE; Demirci M; Sutcu R; Yilmaz N
    Ann Clin Lab Sci; 2006; 36(4):449-54. PubMed ID: 17127734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidised Low-Density Lipoprotein and Its Receptor-Mediated Endothelial Dysfunction Are Associated with Coronary Artery Lesions in Kawasaki Disease.
    He YE; Qiu HX; Wu RZ; Rong X; Xu HT; Xiang RL; Chu MP
    J Cardiovasc Transl Res; 2020 Apr; 13(2):204-214. PubMed ID: 31428922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma thiopurine S-methyltransferase levels and azathioprine-related adverse events in patients with Behçet's disease.
    Emmungil H; Durusoy R; Kalfa M; Yargucu Zihni F; Özmen M; Keser G; Gücenmez S; Yilmaz Z; Aksu K
    Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S40-5. PubMed ID: 25936353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematological Indices May Be Useful in the Diagnosis of Systemic Lupus Erythematosus and in Determining Disease Activity in Behçet's Disease.
    Yolbas S; Yildirim A; Gozel N; Uz B; Koca SS
    Med Princ Pract; 2016; 25(6):510-516. PubMed ID: 27348861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide, lipid peroxidation and antioxidant defence system in patients with active or inactive Behçet's disease.
    Buldanlioglu S; Turkmen S; Ayabakan HB; Yenice N; Vardar M; Dogan S; Mercan E
    Br J Dermatol; 2005 Sep; 153(3):526-30. PubMed ID: 16120137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of lectin-like oxidized low-density lipoprotein-1 receptor protects against plasma-mediated vascular dysfunction associated with pre-eclampsia.
    English FA; McCarthy FP; McSweeney CL; Quon AL; Morton JS; Sawamura T; Davidge ST; Kenny LC
    Am J Hypertens; 2013 Feb; 26(2):279-86. PubMed ID: 23382414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative stress impairs endothelial nitric oxide levels in Behçets' disease.
    Onur E; Kabaroglu C; Inanir I; Var A; Guvenc Y; Gunay O; Gunduz K
    Cutan Ocul Toxicol; 2011 Sep; 30(3):217-20. PubMed ID: 21345164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synovial nitric oxide concentrations are increased and correlated with serum levels in patients with active Behçet's disease: a pilot study.
    Duygulu F; Evereklioglu C; Calis M; Borlu M; Cekmen M; Ascioglu O
    Clin Rheumatol; 2005 Aug; 24(4):324-30. PubMed ID: 15902528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of the oxLDL receptor LOX-1 by endothelin-1 in human endothelial cells.
    Morawietz H; Duerrschmidt N; Niemann B; Galle J; Sawamura T; Holtz J
    Biochem Biophys Res Commun; 2001 Jun; 284(4):961-5. PubMed ID: 11409887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of homocysteine, neopterin and nitric oxide levels in Behçet's disease.
    Ozkan Y; Yardim-Akaydin S; Sepici A; Engin B; Sepici V; Simşek B
    Clin Chem Lab Med; 2007; 45(1):73-7. PubMed ID: 17243919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbamylated low-density lipoprotein induces endothelial dysfunction.
    Speer T; Owala FO; Holy EW; Zewinger S; Frenzel FL; Stähli BE; Razavi M; Triem S; Cvija H; Rohrer L; Seiler S; Heine GH; Jankowski V; Jankowski J; Camici GG; Akhmedov A; Fliser D; Lüscher TF; Tanner FC
    Eur Heart J; 2014 Nov; 35(43):3021-32. PubMed ID: 24658767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased titres of IgM anti-heparan sulfate antibody in Behçet's disease.
    Briani C; Doria A; Marcolongo R; Tognon S; Ruggero S; Toffanin E; Ermani M; Ghirardello A; Zampieri S; Semenzato G
    Clin Exp Rheumatol; 2006; 24(5 Suppl 42):S104-7. PubMed ID: 17067438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [LOX-1 receptor as a novel target in endothelial dysfunction and atherosclerosis].
    Morawietz H
    Dtsch Med Wochenschr; 2010 Feb; 135(7):308-12. PubMed ID: 20146162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary nitric oxide levels are increased and correlated with plasma concentrations in patients with Behçet's disease: is it a new urinary activity marker?
    Evereklioglu C; Ozbek E; Cekmen M; Mehmet N; Duygulu F; Ozkiris A; Calip M; Er H; Turkoz Y
    Nephrology (Carlton); 2003 Oct; 8(5):231-8. PubMed ID: 15012709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum galectin-3 and galectin-3 binding protein levels in Behçet's disease and their association with disease activity.
    Lee YJ; Kang SW; Song JK; Park JJ; Bae YD; Lee EY; Lee EB; Song YW
    Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S41-5. PubMed ID: 17949550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmented endothelial uptake of oxidized low-density lipoprotein in response to endothelin-1.
    Morawietz H; Duerrschmidt N; Niemann B; Galle J; Sawamura T; Holtz J
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():9S-12S. PubMed ID: 12193044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.